Tripti Singh is a Nephrology physician affiliated with University of Wisconsin–Madison. OpenAlex indexes 127 publications with 1,967 citations (h-index 22).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3034 Fish Hatchery Rd
Fitchburg, WI 537133125
Telephone
608-270-5600Provider last certified this registry record 3 Feb 2021.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Travere Therapeutics, Inc.Program year20253 payments
- Novartis Pharmaceuticals CorporationProgram year20252 payments
- Apellis Pharmaceuticals, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
81.9%ACE inhibitor19.7%Lisinopril100%Part D≥30 patientsCalcium channel blocker17.7%Amlodipine Besylate54%Nifedipine Er46%Part D≥21 patients+ 8 more classes in this area
Metabolism & gastrointestinal
8.6%SGLT2 inhibitor5.2%Farxiga100%Part D<11 patientsCorticosteroid3.4%Prednisone100%Part D<11 patientsOther
5.2%Phosphate Binder5.2%Sevelamer Carbonate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- “My Body Is a Ticking Time Bomb”: Associations of Body Mindsets with Psychological Distress in People with Chronic Kidney Disease
International Journal of Behavioral Medicine
2025 - Prescribing Patterns for Sodium-Glucose Cotransporter 2 Inhibitors: A Survey of Nephrologists
Kidney International Reports
2023 - Health economics of kidney replacement therapy in Singapore: Taking stockand looking ahead
Annals of the Academy of Medicine Singapore
2022 - Multidisciplinary Lupus Nephritis Clinic Reduces Time to Renal Biopsy and Improves Care Quality
ACR Open Rheumatology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
William Busse, MD
University of Wisconsin–Madison
David Andes, MD
University of Wisconsin–Madison
Neil Binkley, MD
University of Wisconsin–Madison
Robert Lemanske, MD
University of Wisconsin–Madison
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”